Skip to main content

Table 5 Pathologic complete response in relation to baseline variables

From: Early prediction of pathologic response to neoadjuvant treatment of breast cancer: use of a cell-loss metric based on serum thymidine kinase 1 and tumour volume

Variable

P-value

Stage

0.7427

Pre/Post-menopausal

0.4843

ER < 10>

0.9194

PR < 10>

0.0800

Histological type

0.0989

Lymph nodes

0.2585

Tumour subtype

0.0579

Proliferation value

0.2476

  1. Analysis of variance with pathological complete response in the breast according to baseline variables. Anova with p-values for covariates
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us